Severe Malaria and Anti-malarial Drug Resistance in Cambodia

Clinical Trial ID NCT00341003

PubWeight™ 36.34^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00341003

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.	Nature	2013	11.03
2	Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.	Lancet Infect Dis	2012	6.94
3	Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies.	Lancet Infect Dis	2013	6.06
4	Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia.	Nat Genet	2013	5.22
5	Genetic architecture of artemisinin-resistant Plasmodium falciparum.	Nat Genet	2015	3.03
6	Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.	J Infect Dis	2004	2.82
7	In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon.	Antimicrob Agents Chemother	2003	1.72
8	Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples.	Malar J	2012	1.48
9	Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.	PLoS Pathog	2012	1.43
10	Higher microsatellite diversity in Plasmodium vivax than in sympatric Plasmodium falciparum populations in Pursat, Western Cambodia.	Exp Parasitol	2013	1.05
11	Slow parasite clearance rates in response to artemether in patients with severe malaria.	Lancet Infect Dis	2013	1.04
12	Haemoglobin-E trait and the clinical course of malaria in Thai soldiers.	Eur J Haematol	1990	0.82